The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
暂无分享,去创建一个
J. Cleland | S. Anker | H. Volk | K. Witte | A. Clark | S. von Haehling | N. Nikitin | A. C. Parker
[1] E. Rimm,et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. , 2004, The American journal of clinical nutrition.
[2] J. Salonen,et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. , 2004, The American journal of clinical nutrition.
[3] W. Fawzi,et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. , 2004, The New England journal of medicine.
[4] Ph.D. Prof. S. Jameson M.D.. Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities , 2004, The clinical investigator.
[5] M. Condorelli,et al. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study , 2004, The clinical investigator.
[6] N. Freemantle,et al. The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. , 2003, European heart journal.
[7] N. Freemantle,et al. The heart failure revascularisation trial (HEART): rationale, design and methodology , 2003, European journal of heart failure.
[8] N. Freemantle,et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment , 2003 .
[9] N Freemantle,et al. The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. , 2003, European heart journal.
[10] H. Krum,et al. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure , 2003, BioFactors.
[11] C. R.J.,et al. Statistics with Confidence (2nd ed.) , 2003 .
[12] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[13] S. Stewart,et al. Detecting early clinical deterioration in chronic heart failure patients post‐acute hospitalisation—a critical component of multidisciplinary, home‐based intervention? , 2002, European journal of heart failure.
[14] F. Jeejeebhoy,et al. Nutritional supplementation with MyoVive repletes essential cardiac myocyte nutrients and reduces left ventricular size in patients with left ventricular dysfunction. , 2002, American heart journal.
[15] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[16] J. Steghens,et al. Dietary and blood antioxidants in patients with chronic heart failure. Insights into the potential importance of selenium in heart failure , 2001, European journal of heart failure.
[17] A. Zeiher,et al. Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure , 2001, Circulation.
[18] P. Poole‐Wilson,et al. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. , 2001, European heart journal.
[19] Judea Pearl,et al. Direct and Indirect Effects , 2001, UAI.
[20] J. Cleland,et al. Chronic heart failure and micronutrients. , 2001, Journal of the American College of Cardiology.
[21] Kukin Ml. The Heart Outcomes Prevention Evaluation Study. , 2001, Current cardiology reports.
[22] A. Langer,et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. , 2001, The American journal of clinical nutrition.
[23] J. Cockcroft,et al. Vitamin C acutely improves ejection duration in chronic heart failure (CHF) patients in a heart rate independent fashion , 2000 .
[24] Joanne Eastaugh,et al. The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe , 2000, European journal of heart failure.
[25] M. Fisher,et al. The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure , 2000, Annals of Internal Medicine.
[26] P. Langsjoen. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.
[27] S. Yusuf,et al. Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.
[28] M. Smithson. Statistics with confidence , 2000 .
[29] S. Yusuf,et al. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53. , 2000 .
[30] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[31] Y. J. Kang. The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[32] GISSI-Prevenzione Investigators,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.
[33] Roberto Marchioli,et al. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .
[34] D. Burstow,et al. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 1999, Journal of the American College of Cardiology.
[35] P. Poole‐Wilson,et al. Successes and failures of current treatment of heart failure , 1998, The Lancet.
[36] J. Cleland,et al. Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. , 1998, European heart journal.
[37] A. Omran,et al. Increased oxidative stress in patients with congestive heart failure. , 1998, Journal of the American College of Cardiology.
[38] T. Perneger. What's wrong with Bonferroni adjustments , 1998, BMJ.
[39] H. Drexler,et al. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.
[40] T. Imaizumi,et al. Oxidative stress is related to exercise intolerance in patients with heart failure. , 1998, American heart journal.
[41] S. W. May,et al. Selenium-based antihypertensives. Rationale and potential. , 1998, Drugs.
[42] G. Plotnick,et al. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.
[43] E. Braunwald. Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.
[44] S. Mortensen,et al. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials. , 1997, Molecular aspects of medicine.
[45] M. Motro,et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. , 1995, The American journal of medicine.
[46] K. Swedberg,et al. Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. , 1995, Journal of cardiac failure.
[47] R. Barbour,et al. Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. , 1994, Biochimica et biophysica acta.
[48] A. Favier,et al. Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. , 1993, International journal of cardiology.
[49] J. McMurray,et al. Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.
[50] J. Stamler,et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. , 1993, The Journal of clinical investigation.
[51] I Russell,et al. Statistics--with confidence? , 1991, The British journal of general practice : the journal of the Royal College of General Practitioners.
[52] A. Stewart,et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.
[53] William H. Rogers,et al. Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .
[54] R. Simpson,et al. Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.
[55] G. Guyatt,et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. , 1985, Canadian Medical Association journal.